MedChemBench gives GPT-6.2 Astra 84.5%, while compound selection remains weak
OpenAI has introduced MedChemBench, a 99-problem medicinal chemistry benchmark. GPT-6.2 Astra scored 84.5% at xhigh, but the authors explicitly warn that a retrospective benchmark does not demonstrate new drug discovery or better laboratory decisions.